Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), a biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies for autoimmune diseases and cancer, today announced ...
As the gap in performance shrinks, and there’s less to separate the best from the rest, how will manufacturers react?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback